Chief Business Officer · ENANTA PHARMACEUTICALS INC · Common Stock
Side
F
Value
$7,032
Shares
498
Price
$14.12
Executed
Dec 1, 2025
Disclosed
Dec 3, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 1 executedDec 3, 2025 disclosed
ENTA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$7K reported value · 1.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Luu Brendan filed this Form 4 reporting a tax withholding of ENTA on Dec 1, 2025. It became public on Dec 3, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Luu Brendancik:0001842369
Issuer
ENANTA PHARMACEUTICALS INCcik:0001177648
Revision history · 0
No field has changed since this record was first ingested.
